Post Reply
1-20 of 2420
bought 64 try my luck
ThankYou ( Date: 27-Mar-2023 16:19) Posted:
|
Can buy at 64 bro? Or wait for retracement? Playing contra.
SmallSmall ( Date: 27-Mar-2023 16:16) Posted:
|
This one going against the traffic at recent high..... $0.065
standby to grab 52
Happy New Year 2023!
Pump n dump?
This one better not short. The free float is quite small.
1m too little
xKaiseRx ( Date: 13-Sep-2021 08:55) Posted:
|
No impact on share price .. lols
PhillipTan ( Date: 13-Sep-2021 02:24) Posted:
|
Accrelist to sell 30 percent Accrelist Medical Aesthetics (SPC) stake for S$1M
Accrelist has entered a deal to sell a 30 percent stake in its wholly owned subsidiary Accrelist Medical Aesthetics (SPC) to strategic investor Sri Marilyn Tay Bee Choo for S$1 million, the company said in a filing to SGX Friday.The deal values its SingPost Centre-based clinic, A.M. Aesthetics SPC, at S$3 million, the filing said.
In total, Accrelist has seven local clinics and three in Malaysia, the filing said.
The investor is an entrepreneur involved in the healthcare products and supplements sector, with business across the Asia Pacific region, including Singapore, the filing said.
" Her investment in A.M Aesthetics SPC is expected to add strategic value to the Group' s medical aesthetics and skincare businesses. Dame Dato Sri Marilyn has established extensive connections and built a network of contacts throughout the health and beauty industry through her healthcare products and supplements business and participation in past pageants," Accrelist said.
Terence Tea, executive chairman and managing director of Accrelist, said the company has been encouraged by demand for aesthetics services returning to pre-pandemic levels.
" This adds to our confidence in the long-term prospects of the group' s medical aesthetics business. The strategic investment will further strengthen the group' s financial position and enable Accrelist to capitalise on growth opportunities in the medical aesthetics sector," Tea said in the statement.
Accrelist Medical Aesthetics, or A.M. Aesthetics, reported revenue of S$6.3 million for the fiscal year ended 31 March, up 26 percent on-year, the filing said.
In addition to adding more clinics, A.M. Aesthetics' Bedok Mall and SingPost Centre clinics are both expected to move to larger spaces in the same malls by end-October, more than doubling the number of treatment rooms at each clinic, the filing said.
Accrelist welcomes strategic investor to enhance its medical aesthetics and skincare business
&bull Accrelist secures S$1 million investment for a 30% stake in its wholly-owned subsidiary, Accrelist Medical Aesthetics (SPC) Pte. Ltd.,
which translates into an estimated worth of S$3 million for its SingPost Centre clinic (A.M Aesthetics SPC). Accrelist has 7 local clinics and 3 overseas branches in Malaysia.
&bull Accrelist secures S$1 million investment for a 30% stake in its wholly-owned subsidiary, Accrelist Medical Aesthetics (SPC) Pte. Ltd.,
which translates into an estimated worth of S$3 million for its SingPost Centre clinic (A.M Aesthetics SPC). Accrelist has 7 local clinics and 3 overseas branches in Malaysia.
This one silent killer moves.....high goes higher
Now is golden period of penny stock!
can go 10?
Another $0.10 counter. Small float after massice consolidaytion
Accrelist to raise up to S$3.38m via proposed placement of shares, issue of warrants
Catalist-listed Accrelist is planning to raise up to S$3.38 million through the placement of shares and issuance of warrants to facilitate its growth plans as it seeks to ride on the rising demand for medical aesthetics services.In a filing to the Singapore Exchange on Wednesday, Accrelist said that it had entered into conditional placement letters with six placees to purchase or subscribe for 22 million ordinary shares at an issue price of S$0.07371, which represents a discount of 10 per cent over the volume-weighted average price of S$0.0819 for trades done on the Singapore Exchange on Monday this week.
The placees, who are private investors, were introduced to the company by a third party, who will receive an introduction fee of 3 per cent per placement share. This will be fulfilled through the issuance of up to 660,000 shares in Accrelist at the placement price.
In addition, the company has agreed to constitute 22 million non-listed, transferable warrants to the placees, on the basis of one warrant for every placement share subscribed. Each warrant carries the right to subscribe for one share at the exercise price of S$0.08 and are exercisable within one year from the date of issue.
The 22 million shares work out to 7.88 per cent of the company' s issued share capital as at Wednesday, and 6.79 per cent of the company' s enlarged share capital after taking into account the issuance of the placement shares, introducer shares and warrant shares.
Assuming that the placement shares are fully placed out and the warrants are fully exercised, Accrelist will raise S$3.38 million.
Terence Tea, executive chairman and managing director of Accrelist, said: " We decided to undertake the proposed placement to strengthen the group' s financial position and enable Accrelist to capitalise on growth opportunities in the medical aesthetics sector. As Covid-19 restrictions are gradually eased, we are encouraged by the demand for medical aesthetics services, which has returned to pre-pandemic levels."
Its unit Accrelist Medical Aesthetics (A.M Aesthetics) generated revenues of S$6.3 million for the financial year ended March 31, 2021, up from S$5 million in the prior financial year. It has expanded from four local clinics in 2018 to seven local clinics across Singapore and three overseas branches in Malaysia. In Singapore, it opened its Serangoon Central clinic and flagship Raffles City Shopping Centre clinic earlier this year.
Meanwhile, A.M Aesthetics' existing clinics at Bedok Mall and SingPost Centre clinics are expected to shift to bigger spaces at both malls by the end of October, while the group continues to expand its clinical skincare products business, A.M Skincare, to broaden its revenue streams, it said.
Shares in Accrelist were halted from trading on Tuesday morning, pending the release of the announcement.
up trend
time to move?
bought 63 durians
noobnub ( Date: 30-Jul-2021 17:02) Posted:
|
so much durians 64
noobnub ( Date: 30-Jul-2021 16:45) Posted:
|